Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John R Sims

Showing results (1-10 of 99) with videos related to

Pageof 10
Sort By:
Neurocritical Care|August 13, 2008
Dantrolene: mechanisms of neuroprotection and possible clinical applications in the neurointensive care unitSusanne Muehlschlegel, John R Sims
American Journal of Otolaryngology|December 28, 2017
Primary surgical management with radial forearm free flap reconstruction in T4 oropharyngeal cancer: Complications and functional outcomesJohn R Sims, Eric J Moore
JAMA|December 19, 2023
Use of Donanemab in Early Symptomatic Alzheimer Disease-ReplyCynthia D Evans, John R Sims
Head & Neck|September 19, 2012
First bite syndrome: case report of 3 patients treated with botulinum toxin and review of other treatment modalitiesJohn R Sims, James Y Suen
The Open Neuroimaging Journal|November 20, 2008
Restricted diffusion in the splenium of the corpus callosum after cardiac arrestMatt T Bianchi, John R Sims
Neurology|September 26, 2012
Neurocritical care and periprocedural blood pressure management in acute strokeKevin N Sheth, John R Sims
Seizure|April 22, 2014
How predictive are photosensitive epilepsy models as proof of principle trials for epilepsy?Eunice S M Yuen, John R Sims
Neurology|February 13, 2008
Teaching NeuroImage: Cerebral T-waves from an aneurysmal cardunculus compressionSusanne Muehlschlegel, Richard P Goddeau, John R Sims
The New England Journal of Medicine|August 11, 2021
Donanemab in Early Alzheimer's Disease. ReplyMark A Mintun, Alette M Wessels, John R Sims
Aviation, Space, and Environmental Medicine|May 22, 2004
Neoprene wet-suit hood affects low-frequency underwater hearing thresholdsDavid M Fothergill, John R Sims, Michael D Curley
Pageof 10

Showing results (1-10 of 99) with videos related to

Sort By:
Pageof 10
Neurocritical Care|August 13, 2008
Dantrolene: mechanisms of neuroprotection and possible clinical applications in the neurointensive care unitSusanne Muehlschlegel, John R Sims
American Journal of Otolaryngology|December 28, 2017
Primary surgical management with radial forearm free flap reconstruction in T4 oropharyngeal cancer: Complications and functional outcomesJohn R Sims, Eric J Moore
JAMA|December 19, 2023
Use of Donanemab in Early Symptomatic Alzheimer Disease-ReplyCynthia D Evans, John R Sims
Head & Neck|September 19, 2012
First bite syndrome: case report of 3 patients treated with botulinum toxin and review of other treatment modalitiesJohn R Sims, James Y Suen
The Open Neuroimaging Journal|November 20, 2008
Restricted diffusion in the splenium of the corpus callosum after cardiac arrestMatt T Bianchi, John R Sims
Neurology|September 26, 2012
Neurocritical care and periprocedural blood pressure management in acute strokeKevin N Sheth, John R Sims
Seizure|April 22, 2014
How predictive are photosensitive epilepsy models as proof of principle trials for epilepsy?Eunice S M Yuen, John R Sims
Neurology|February 13, 2008
Teaching NeuroImage: Cerebral T-waves from an aneurysmal cardunculus compressionSusanne Muehlschlegel, Richard P Goddeau, John R Sims
The New England Journal of Medicine|August 11, 2021
Donanemab in Early Alzheimer's Disease. ReplyMark A Mintun, Alette M Wessels, John R Sims
Aviation, Space, and Environmental Medicine|May 22, 2004
Neoprene wet-suit hood affects low-frequency underwater hearing thresholdsDavid M Fothergill, John R Sims, Michael D Curley
Pageof 10